Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors

BACKGROUND: Malignant peripheral nerve sheath tumors (MPNST) are rare highly aggressive sarcomas that affect 8-13% of people with neurofibromatosis type 1. The prognosis for patients with MPNST is very poor. Despite TOP2A overexpression in these tumors, doxorubicin resistance is common, and the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Peacock, Jacqueline D, Cherba, David, Kampfschulte, Kevin, Smith, Mallory K, Monks, Noel R, Webb, Craig P, Steensma, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848568/
https://www.ncbi.nlm.nih.gov/pubmed/24040940
http://dx.doi.org/10.1186/1479-5876-11-213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848568/
https://www.ncbi.nlm.nih.gov/pubmed/24040940
http://dx.doi.org/10.1186/1479-5876-11-213

Ejemplares similares